These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 16457286
21. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer. Furuse J, Okusaka T, Ohkawa S, Nagase M, Funakoshi A, Boku N, Yamao K, Yamaguchi T, Sato T. Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641 [Abstract] [Full Text] [Related]
22. Implantation metastasis following external biliary drainage in biliary tract cancers--cause for concern! Srivastava S, Sikora SS. Hepatogastroenterology; 2000 Dec; 47(36):1535-7. PubMed ID: 11148996 [Abstract] [Full Text] [Related]
23. Bile cytology. Diagnostic role in the management of biliary obstruction. Nilsson B, Wee A, Yap I. Acta Cytol; 1995 Dec; 39(4):746-52. PubMed ID: 7631549 [Abstract] [Full Text] [Related]
24. Adenosquamous carcinoma of the extrahepatic biliary tract: clinicopathological analysis of Japanese cases of this uncommon disease. Okabayashi T, Kobayashi M, Nishimori I, Namikawa T, Okamoto K, Onishi S, Araki K. J Gastroenterol; 2005 Feb; 40(2):192-9. PubMed ID: 15770404 [Abstract] [Full Text] [Related]
26. [Indication for and problems of hepatopancreatoduodenectomy for carcinoma of the biliary tract based on the statistical registry in Japan]. Nagakawa T, Kayahara M. Nihon Geka Gakkai Zasshi; 2001 Feb; 102(2):199-202. PubMed ID: 11260900 [Abstract] [Full Text] [Related]
27. [Cytological diagnosis of neoplasms of the duodenal, hepatic, pancreatic and biliary system]. Shida S, Matsuzawa Y, Muto K, Takada E. Rinsho Byori; 1980 Feb; Suppl():165-76. PubMed ID: 7411956 [No Abstract] [Full Text] [Related]
32. Factors affecting the yield of brush cytology for the diagnosis of pancreatic and biliary cancers. Parsi MA, Deepinder F, Lopez R, Stevens T, Dodig M, Zuccaro G. Pancreas; 2011 Jan; 40(1):52-4. PubMed ID: 20871478 [Abstract] [Full Text] [Related]
33. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer. Furuse J, Okusaka T, Funakoshi A, Yamao K, Nagase M, Ishii H, Nakachi K, Ueno H, Ikeda M, Morizane C, Horikawa Y, Mizuno N. Jpn J Clin Oncol; 2006 Sep; 36(9):552-6. PubMed ID: 16887837 [Abstract] [Full Text] [Related]
34. [Treatment of biliary tract cancer]. Ouchi K, Matsuno S, Sato T. Gan No Rinsho; 1989 Jan; Spec No():316-21. PubMed ID: 2915483 [No Abstract] [Full Text] [Related]
35. [Bile cytology for biliary tract cancer]. Noda Y, Ito K, Koshita S, Kanno Y, Sawai T. Nihon Rinsho; 2015 Mar; 73 Suppl 3():524-9. PubMed ID: 25857080 [No Abstract] [Full Text] [Related]
37. [Biliary tract carcinomas. II. Biliary tract cancer]. Merdzhanov A, Damianov D, Aleksandrova A, Evtimov G. Vutr Boles; 1981 Mar; 20(5):39-45. PubMed ID: 6275611 [Abstract] [Full Text] [Related]
38. Prognostic impact of regional lymph node micrometastasis in patients with node-negative biliary cancer. Yonemori A, Kondo S, Matsuno Y, Ito T, Nakanishi Y, Miyamoto M, Tanaka E, Hirano S. Ann Surg; 2010 Jul; 252(1):99-106. PubMed ID: 20505505 [Abstract] [Full Text] [Related]
39. Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy. Saisho T, Okusaka T, Ueno H, Morizane C, Okada S. Hepatogastroenterology; 2005 Jul; 52(66):1654-8. PubMed ID: 16334750 [Abstract] [Full Text] [Related]